The Cancer Molecular Therapeutics Research Association [CMTRA] was created in 2008 to organize and host the annual Molecular Therapeutics of Cancer meeting. The meeting objective is to provide a forum for presentation and discussion of contemporary research in the field of cancer drug development and therapy. Modeled after small Gordon-type conferences, the meeting provides an opportunity for young and established researchers to discuss and challenge current paradigms for cancer drug development and therapy, as well as a venue where novel ideas can be presented with anticipation of lively debate. The CMTRA (Cancer Molecular Therapeutics Research Association) meeting will provide a highly interactive forum for the presentation and discussion of novel drugs, drug targets, and the preclinical and clinical development of novel cancer therapeutics.